Irwin Simon

No Cannabis Tax Relief In Canada, Tilray CEO Says This 'Hinders Our Ability To Compete With The Illicit Market'
Tilray CEO Irwin Simon Visits Israel To Meet Business Partners And Germany Ahead Of Imminent Legalization
Corona Beer Maker Walks Away From Remaining Warrants Of Weed Giant Canopy Growth
Tilray CEO Irwin Simon Visits Israel To Meet Business Partners And Germany Ahead Of Imminent Legalization
Corona Beer Maker Walks Away From Remaining Warrants Of Weed Giant Canopy Growth
Tilray's Trifecta: CEO Irwin Simon Says Cannabis Company Well-Positioned Around Weed, Beer, Food
Medical Cannabis In Canada Faces Decline: What's Behind The 38% Drop In Registrations?

Irwin Simon Recent News

Not Even Tilray Is Impervious To This Cannabis Industry Trend: Pot Giant Is Latest To Lay Off Staff
Tilray Brands (NASDAQ: TLRY), will lay off 49 employees at medical cannabis cultivation and manufacturing facility in Cantanhede, Portugal, reported Jornal de Notícias.
Key Cannabis Exec Changes Investors Should Know About: ScottsMiracle Gro, Tilray, Metrc, & Willow Industries
ScottsMiracle-Gro Nominates Edith Avilés To Board Of Directors
Jim Cramer Is Bullish On Cannabis Stocks Ahead Of Midterm Elections: 'I Say Buy Tilray'
Mad Money host Jim Cramer said last week during a Lightning Round segment that now is a good time to invest in Tilray.
Tilray Net Loss Nearly Doubles From Year Ago, But Biden Marijuana Pardons Keep The Stock Up
Canadian marijuana giant Tilray Brands, Inc. (NASDAQ: TLRY) (TSX:TLRY) reported Friday financial results for the first fiscal quarter ended August 31, 2022, with net revenue of $153.2 million, which compares to revenue of $168.02 million for the same period last year.
A Shareholder Lawsuit Stemming From Aphria Could Expose Tilray—Trouble In Cannabis Paradise?
Canadian cannabis giant Tilray, Inc. (NASDAQ: TLRY), which closed its acquisition of rival Aphria, Inc. (APHA) in 2021, could face a lawsuit brought by former Aphria shareholders.
EXCLUSIVE: Tilray CEO Shares Insider Insights Into Earnings, International Opportunities, Alcohol Market & More
Tilray Brands Inc.'s (NASDAQ: TLRY) CEO Irwin Simon said on Thursday's "Cannabis Insider" that "Europe will legalize [cannabis] before the U.S."
Tilray Launches Medical Cannabis Education Resource
Tilray Brands, Inc. (NASDAQ: TLRY), a Canada-based cannabis company, announced on Tuesday that subsidiary Tilray Medical has launched a new educational platform called WeCare-MedicalCannabis to provide education about the benefits of medical cannabis to consumers and medical practitioners
Tilray Will Cover Employees' Travel, Accommodation & Paid Time Off For Women Seeking Reproductive Care
Tilray Brands Inc. (NASDAQ: TLRY) is joining other companies that are committing to help their employees travel to other states, following SCOTUS' decision to overturn Roe v.
This Analyst Has Mixed Feelings About Tilray's Promise To Achieve $4B In Revenue By 2024, Here's Why
Tilray Brands' (NASDAQ: TLRY) stock has plunged nearly 30% year-to-date.
EXCLUSIVE: Irwin Simon, CEO, 'Tilray Will Own Canada, And It Will Get Bigger'
“Almost 4:20 on 4/20, pretty exciting,” said CNBC reporter Frank Holland as he welcomed the crowd at Benzinga’s Cannabis Capital Conference before interviewing Irwin Simon, CEO of Tilray inc. (NASDAQ
Tilray Q3 Revenue Grows 23% YoY To $152M, Gives Update On Targeted Cost Synergies From Aphria Deal
Tilray To Report Q3 Financial Highlights On Heels Of Deal With HEXO
Simon Says Legalize: Tilray CEO Makes The Case For Cannabis
Cannabis stocks continue to rise Friday following reports the U.S. House Rules Committee plans to meet next week to prepare a federal marijuana legalization bill for floor action.
Can't Sleep? Tilray's Solei Brand Launches 'Renewed Moonlight' THC And CBN Vape Pen
Tilray Brands, Inc. (Nasdaq:TLRY) (TSX:TLRY) launched Renew Moonlight, a new CBN vape pen designed for nighttime use by wellness brand, Solei. Joining Solei's portfolio of wellness products, this high-CBN vape pen with a potency of 4:1 THC and CBN is blended with citrus and herbal aromas.
Tilray Poised To Conquer Malta's Medical Marijuana Market - Launches First Medical Cannabis Oil
Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY) confrimed Thursday that its medical cannabis division, Tilray Medical, has expanded its medical cannabis offering and launched the first EU GMP medical cannabis oil products in Malta.
What Does Tilray Get From HEXO Debt Deal? Analyst Says 'Chapeau!' To CEO Irwin Simon
On Thursday, HEXO Corp. (NASDAQ: HEXO) finalized a strategic partnership with Tilray Brands, Inc.
Aurora Cannabis Is Selling Stock To Pay Off Debt: Why Tilray And Canopy Could Be Next In Line
Earlier this month, Aurora Cannabis (NASDAQ: ABC) reported its second-quarter financial results, revealing a 10% decline in total net revenue, which totaled slig
EXCLUSIVE: 'I Don't Want To Be Elon Musk' Or The Tesla Of Weed, Says Tilray CEO
Tilray, Inc. (NASDAQ: TLRY) reported its financial results on Monday for the second fiscal quarter ended Nov. 30, 2021, with net revenue of $155 million - up by around 20% year-over-year and down from $168 million in the first fiscal quarter
Tilray CEO Irwin Simon To Give Keynote At Benzinga Cannabis Capital Conference In April
Benzinga, a financial news and data company announced that Irwin Simon, CEO of cannabis giant Tilray Brands, Inc.
Tilray Buys Two California Craft Beer Brands For $5.1M
Tilray Inc.
Why Tilray Shares Are Rising Today
Tilray Inc (NASDAQ: TLRY) is trading higher Monday morning after the company announced fiscal second-quarter 2022 financial results showing revenue increased year-over-year and the company reached profitability. 
These 2 Cannabis Stocks Were Among The Most Searched Benzinga Tickers In 2021: Here's Why
Among the 20 most searched tickers on Benzinga in 2021 were two well-known cannabis companies. Here are their names and why they were heavily searched in 2021.